questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines ribosomiques
Facteurs initiation chaîne peptidique
Facteurs d'initiation eucaryotes
Facteur-4F d'initiation eucaryote
Facteur-4G d'initiation eucaryote
Facteur-4G d'initiation eucaryote : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Facteur d'initiation eucaryote
Analyse protéomique
Biopsie
Analyse tissulaire
Marqueurs biologiques
ARNm
Imagerie médicale
Complications
Symptômes
5
Troubles de croissance
Anomalies métaboliques
Troubles neurologiques
Traduction
Âge
Manifestations cliniques
Système immunitaire
Dysfonction
Prévention
5
Prévention
Dépistage génétique
Conseils nutritionnels
Mode de vie
Suivi médical
Détection précoce
Éducation génétique
Prise de décision
Traitements
5
Thérapie génique
Médicaments ciblés
Nutrition
Fonction cellulaire
Essais cliniques
Thérapies expérimentales
Médecine personnalisée
Mutations
Efficacité
Réponse au traitement
Complications
5
Complications
Troubles métaboliques
Gravité
Intervention médicale
Complications chroniques
Qualité de vie
Prévention
Traitement précoce
Gestion des complications
Suivi médical
Facteurs de risque
5
Facteurs de risque
Mutations génétiques
Facteurs environnementaux
Expression génique
Alimentation
Fonction cellulaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteur-4G d'initiation eucaryote : Questions médicales les plus fréquentes",
"headline": "Facteur-4G d'initiation eucaryote : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteur-4G d'initiation eucaryote : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-07",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteur-4G d'initiation eucaryote"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteur-4F d'initiation eucaryote",
"url": "https://questionsmedicales.fr/mesh/D039562",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4F d'initiation eucaryote",
"code": {
"@type": "MedicalCode",
"code": "D039562",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.835.725.868.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4G d'initiation eucaryote",
"alternateName": "Eukaryotic Initiation Factor-4G",
"code": {
"@type": "MedicalCode",
"code": "D039603",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Johannes Haybaeck",
"url": "https://questionsmedicales.fr/author/Johannes%20Haybaeck",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria; johannes.haybaeck@i-med.ac.at."
}
},
{
"@type": "Person",
"name": "Jerry Pelletier",
"url": "https://questionsmedicales.fr/author/Jerry%20Pelletier",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, McGill University, Montreal, QC, Canada."
}
},
{
"@type": "Person",
"name": "Wei Chen",
"url": "https://questionsmedicales.fr/author/Wei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Cancer Institute of Integrated Traditional Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, PR China. viogro@163.com."
}
},
{
"@type": "Person",
"name": "Katherine L B Borden",
"url": "https://questionsmedicales.fr/author/Katherine%20L%20B%20Borden",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada."
}
},
{
"@type": "Person",
"name": "Piotr Czapiewski",
"url": "https://questionsmedicales.fr/author/Piotr%20Czapiewski",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, Municipal Clinic Dessau, Dessau-Roßlau, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An evaluation of the relationship between clinical requirements and tests of competence in a competency-based curriculum in dentistry.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12909-023-04438-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Understanding Clinical Competence: Understanding Student Assessment.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/36814123",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Redesigning a Clinical Advancement Program to Promote and Strengthen Competencies of Clinical Nurses.",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35973194",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/NNA.0000000000001183"
}
},
{
"@type": "ScholarlyArticle",
"name": "A multispecialty ethnographic study of clinical competency committees (CCCs).",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35635737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0142159X.2022.2072281"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between learning styles and clinical competency in nursing students.",
"datePublished": "2024-04-26",
"url": "https://questionsmedicales.fr/article/38671438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12909-024-05432-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines ribosomiques",
"item": "https://questionsmedicales.fr/mesh/D012269"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs initiation chaîne peptidique",
"item": "https://questionsmedicales.fr/mesh/D010448"
},
{
"@type": "ListItem",
"position": 6,
"name": "Facteurs d'initiation eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D039642"
},
{
"@type": "ListItem",
"position": 7,
"name": "Facteur-4F d'initiation eucaryote",
"item": "https://questionsmedicales.fr/mesh/D039562"
},
{
"@type": "ListItem",
"position": 8,
"name": "Facteur-4G d'initiation eucaryote",
"item": "https://questionsmedicales.fr/mesh/D039603"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteur-4G d'initiation eucaryote - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteur-4G d'initiation eucaryote",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteur-4G d'initiation eucaryote",
"description": "Comment diagnostiquer une anomalie d'eIF-4G ?\nQuels tests sont utilisés pour évaluer eIF-4G ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels marqueurs biologiques sont associés à eIF-4G ?\nL'imagerie est-elle utile pour diagnostiquer des troubles liés à eIF-4G ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteur-4G d'initiation eucaryote",
"description": "Quels symptômes sont liés à une dysfonction d'eIF-4G ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes immunitaires peuvent-ils apparaître ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteur-4G d'initiation eucaryote",
"description": "Peut-on prévenir les troubles liés à eIF-4G ?\nY a-t-il des mesures préventives recommandées ?\nLe suivi médical est-il important ?\nLes vaccinations peuvent-elles aider ?\nL'éducation génétique est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteur-4G d'initiation eucaryote",
"description": "Quels traitements sont disponibles pour les troubles d'eIF-4G ?\nLa nutrition joue-t-elle un rôle dans le traitement ?\nDes thérapies expérimentales existent-elles ?\nLes traitements sont-ils personnalisés ?\nLes traitements sont-ils efficaces à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteur-4G d'initiation eucaryote",
"description": "Quelles complications peuvent survenir avec eIF-4G ?\nLes complications sont-elles graves ?\nY a-t-il des complications à long terme ?\nLes complications peuvent-elles être évitées ?\nComment gérer les complications liées à eIF-4G ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteur-4G d'initiation eucaryote",
"description": "Quels sont les facteurs de risque pour eIF-4G ?\nL'environnement influence-t-il eIF-4G ?\nL'alimentation peut-elle être un facteur de risque ?\nLes infections jouent-elles un rôle ?\nLe stress a-t-il un impact sur eIF-4G ?",
"url": "https://questionsmedicales.fr/mesh/D039603?mesh_terms=Clinical+Competence#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie d'eIF-4G ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses protéomiques peuvent identifier des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer eIF-4G ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse et la PCR pour détecter des mutations."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies tissulaires peuvent révéler des niveaux anormaux d'eIF-4G."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés à eIF-4G ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux de protéines spécifiques et des ARNm peuvent servir de marqueurs."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle utile pour diagnostiquer des troubles liés à eIF-4G ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer des complications, mais pas directement eIF-4G."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysfonction d'eIF-4G ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de croissance et des anomalies métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison d'une mauvaise traduction."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment selon l'âge du patient."
}
},
{
"@type": "Question",
"name": "Des symptômes immunitaires peuvent-ils apparaître ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction d'eIF-4G peut affecter le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause sous-jacente et de la rapidité du traitement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés à eIF-4G ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage génétique peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conseils sur la nutrition et le mode de vie peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier peut aider à détecter des problèmes précocement."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas directement les troubles d'eIF-4G."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle utile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider à la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles d'eIF-4G ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des thérapies géniques et des médicaments ciblés."
}
},
{
"@type": "Question",
"name": "La nutrition joue-t-elle un rôle dans le traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une nutrition adéquate peut soutenir la fonction cellulaire et la traduction."
}
},
{
"@type": "Question",
"name": "Des thérapies expérimentales existent-elles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent de nouvelles approches thérapeutiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des mutations spécifiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité dépend de la nature de la dysfonction et de la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec eIF-4G ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques et des problèmes de croissance."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être graves et nécessiter une intervention médicale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications chroniques peuvent affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à eIF-4G ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour eIF-4G ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des mutations génétiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'environnement influence-t-il eIF-4G ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent affecter l'expression d'eIF-4G."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle être un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut influencer la fonction d'eIF-4G."
}
},
{
"@type": "Question",
"name": "Les infections jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent perturber la fonction d'eIF-4G et provoquer des troubles."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur eIF-4G ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la régulation de l'expression d'eIF-4G."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria; johannes.haybaeck@i-med.ac.at.
Diagnostic & Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz, Graz, Austria.
Publications dans "Facteur-4G d'initiation eucaryote" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, McGill University, Montreal, QC, Canada.
Rosalind & Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada.
Centre de Recherche en Biologie Structurale (CRBS), McGill University, Montreal, QC, Canada.
Department of Oncology, McGill University, Montreal, QC, Canada.
McGill Research Center on Complex Traits, McGill University, Montreal, QC, Canada.
Publications dans "Facteur-4G d'initiation eucaryote" :
4 publications dans cette catégorie
Affiliations :
Cancer Institute of Integrated Traditional Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, PR China. viogro@163.com.
Publications dans "Facteur-4G d'initiation eucaryote" :
3 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada.
Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada.
Publications dans "Facteur-4G d'initiation eucaryote" :
3 publications dans cette catégorie
Affiliations :
Institute of Pathology, Municipal Clinic Dessau, Dessau-Roßlau, Germany.
Publications dans "Facteur-4G d'initiation eucaryote" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology and Venereology, Medical University of Graz, Austria.
Publications dans "Facteur-4G d'initiation eucaryote" :
3 publications dans cette catégorie
Affiliations :
Department of Biotechnology and Bioinformatics, University of Kashmir, Srinagar, Jammu and Kashmir, India.
Publications dans "Facteur-4G d'initiation eucaryote" :
3 publications dans cette catégorie
Affiliations :
Department of Biotechnology and Bioinformatics, University of Kashmir, Srinagar, Jammu and Kashmir, India.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616. Electronic address: csfraser@ucdavis.edu.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, McGill University, Montreal, QC, Canada.
Rosalind & Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada.
Centre de Recherche en Biologie Structurale (CRBS), McGill University, Montreal, QC, Canada.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada.
Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Dessau Medical Center and Brandenburg Medical School Theodor Fontane, Dessau-Roßlau, Germany.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Diagnostic and Research Center for Molecular BioMedicine, Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Publications dans "Facteur-4G d'initiation eucaryote" :
2 publications dans cette catégorie
Affiliations :
Diagnostic and Research Center for Molecular BioMedicine, Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Publications dans "Facteur-4G d'initiation eucaryote" :
The development of competencies in dentistry is a complicated process that calls for the development of not just cognitive and psychomotor abilities but also behaviors and attitudes that change as tec...
Retrospective assessment data for 81 students were used in this analysis. Data included the amounts of clinical requirements completed for operative dentistry, endodontics, periodontics, and fixed pro...
Fixed prosthodontics and posterior endodontics were the least common procedures completed by dental students. Statistically significant weak correlations were found between the amounts of clinical req...
The null hypothesis was rejected since a positive correlation was found between the absolute clinical requirements completed and grades in tests of competence. However, only a weak to moderate degree ...
The extent, purpose, and model of performance assessment should be guided by our understanding of clinical competence. We have come a long way from believing that competence is generic, fixed, and tra...
Clinical advancement programs (CAPs) benefit direct care nursing staff, patients, and healthcare institutions. As standards in nursing practice and workforce evolve, changes in CAPs are necessary. In ...
Clinical competency committees (CCCs) assess residents' performance on their specialty specific milestones, however there is no 'one-size fits all' blueprint for accomplishing this. Thus, CCCs have ha...
We purposefully sampled CCCs across multiple specialties and institutions. Data from three sources were triangulated: (1) online demographic survey, (2) ethnographic observations of CCC meetings and (...
Sixteen observations were completed with 15 different CCCs at 9 institutions. Three main thematic categories that impact the operations of CCCs emerged: (1) Membership structure and members roles, (2)...
While CCCs used some known effective practices, substantial variation in structure and processes was notable across CCCs. Future work should explore the impact of this variation on educational outcome...
The acquisition of clinical competence is considered the ultimate goal of nursing education programs. This study explored the relationship between learning styles and clinical competency in undergradu...
A descriptive-correlational study was conducted in 2023 with 276 nursing students from the second to sixth semesters at Abhar School of Nursing, Zanjan University of Medical Sciences, Iran. Data were ...
The predominant learning styles among nursing students were divergent (31.2%), and the least common was convergent (18.4%). The overall clinical competency score was 77.25 ± 12.65. Also, there was a s...
The results of this study showed the association between learning styles and clinical competence in nursing students. It is recommended that educational programs identify talented students and provide...
To synthesize and analyze the literature on nursing clinical competence to assess the factors affecting nursing clinical competency....
Nursing competence affects not only patients but also nurses themselves. Competent nurses contribute to patient safety. Prioritizing clinical competency enables nurses to deliver high-quality care. Cl...
This was a systematic review....
This study utilized an extensive literature search of online databases, including SCOPUS, Web of Science and PubMed. This review followed the guidelines provided by the Effective Practice and Organiza...
This systematic review provided 20 valuable articles, with a total of 6273 participants across the 20 studies, including 18 cross-sectional studies and two descriptive-correlational studies, predomina...
Understanding and addressing these factors are crucial for enhancing nurses' clinical competence and ultimately improving patient outcomes. Further research and interventions should be directed toward...
The clinical standards of dentists are never re-assessed and the dental regulator, unlike the General Medical Council, has not introduced revalidation; therefore, the clinical standards of a dentist a...
Much of the research on nursing informatics competence has been conducted in a Western context. Thus, this study aimed to develop the Korean Nursing Informatics Competence Assessment Scale for clinica...
In real-world medical education, there is a lack of reliable predictors of future clinical competencies. Hence, we aim to identify the factors associated with clinical competencies and construct a pre...
We analyzed data from medical students who graduated from National Yang-Ming University with clerkship training and participated in the postgraduate year (PGY) interview at Taipei Veterans General Hos...
Medical school grades were associated with the performance of national OSCEs (Pearson r = 0.34, p = 0.017), but the grades of the structured PGY interviews were marginally associated with the national...
Our study suggests that interventions for students with unsatisfactory medical school grades are warranted to improve their clinical competencies....
Designing competency-based education (CBE) programmes is a priority in global nursing education for better nursing care for the population. In the Democratic Republic of the Congo (DRC), object-based ...
A qualitative descriptive approach with conventional content analysis was applied. Twenty interviews with clinical supervisors who oversaw both CBE- and OBE-trained nurses, 22 focus group discussions ...
The supervisors recognised that the CBE-trained nurses had stronger competencies in professional communication, making decisions about health problems, and engaging in professional development, but we...
The study results support the Ministry of Health's policy to expand CBE in pre-service education programmes but reveal that its slow implementation impedes full utilisation of the acquired competencie...